Меню
КартаВръзкиТемиБългарияНощта (K-TRIO)Мария Склодовска-КюриЗа ученициЗа учителиМетодологияИзненадай ме
H2020Докторантска мрежа2020–2025

PHAST · Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy

„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“

Период
2020-09-01 → 2025-01-31
Финансиране от ЕС
3 939 918 €
Участници
14
Схема
MSCA-ITN

Линиите свързват координатора с партньорите.

Накратко на български

Оптичните технологии се използват за ранна диагностика и проследяване на рака, например чрез светлинна спектроскопия и сензори с оптични влакна. Това помага за по-точно определяне на границите на туморите по време на операции и по-добър контрол върху терапията.

Този кратък обзор е генериран от изкуствен интелект

Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.

Резултати накратко

Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy

The PHAST-ETN project has developed a comprehensive and innovative doctoral training programme in biophotonics to advance diagnostics and therapy in oncology. The project aims to shape a new generation of highly skilled, multidisciplinary scientists by offering a personalized PhD track encompassing research, technological innovation, and clinical translation. The focus lies on early cancer diagnosis, targeted treatment, and non-invasive therapy monitoring through optical technologies. The research and training activities are structured around four main objectives: 1. In-vitro cancer diagnosis using optical spectroscopy paired with novel sampling techniques for point-of-care (POC) applications. 2. Tissue diagnostics and functional monitoring through optical fibre-based biopsy and diffuse optical spectroscopy. 3. Microscale therapy guidance by real-time optical imaging of tumour margins during surgical procedures. 4. Macroscale therapy effectiveness monitoring via diffuse spectroscopy, fibre sensors, and multimodal imaging systems.

Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз

Цел на проекта

The European Training Network PHAST (Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy) provides excellent, highly-skilled education and training in the vibrant field of Biophotonics for 15 Early Stage Researchers (ESRs) in a strong multidisciplinary PhD programme. PHAST addresses some relevant “unmet needs” of the medical community in prevention, diagnosis and treatment of cancer – one of the leading causes of death worldwide – to significantly improve the quality of life for European society. The main scientific goal of PHAST is to develop multiscale advanced photonic technologies for the diagnosis of cancer in vitro and in vivo and the monitoring of therapy for personalized medicine, through its four specific objectives: 1. In-vitro diagnosis as point-of-care approach through optical spectroscopy combined with innovative sampling techniques. 2. Tissue diagnostics and functional monitoring by optical fibre-based biopsy and diffuse optical spectroscopy. 3. Microscale cancer monitoring by multimodal optical imaging of tumour borders during surgery. 4. Macroscale therapy monitoring by diffuse optical spectroscopy, multifunctional optical fibre sensors, autofluorescence, and hyperspectral imaging. The multi-scale level approach employed by PHAST will allow early cancer detection from molecular disease markers in body-liquids up to live organs. In specific cases these techniques will be validated in the clinic thanks to close collaboration with medical institutions. The ESRs will be trained to all the technologies through hands-on laboratory platforms, thematic workshops and courses to build solid careers as biophotonics professionals in both academic and non-academic sectors. This will be possible thanks to the multidisciplinary environment created by the PHAST consortium, composed of research institutions, 2 hospitals and 8 industries, among them specialized small companies as well as global players in the field such as Horiba, Philips and Zeiss.

Оригинален текст от CORDIS (на английски).

Участници

Връзки

Данни: CORDIS, © Европейски съюз